Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

KIROPRAKTORKLINIKKEN 360 SUNDHED ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6% 0.6%   Bankruptcy risk   2.1% 1.8% 1.9% 1.4% 1.4% 1.5% 12.8% 12.8%   Credit score (0-100)   69 73 69 77 77 75 18 18   Credit rating   A A A A A A BB BB   Credit limit (kDKK)   0.1 1.2 0.4 21.5 17.7 10.7 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   982 1,193 1,344 1,559 1,353 1,379 0.0 0.0   EBITDA   182 300 516 818 837 717 0.0 0.0   EBIT   165 291 506 805 819 698 0.0 0.0   Pre-tax profit (PTP)   182.0 312.0 526.9 847.5 854.2 749.7 0.0 0.0   Net earnings   139.9 243.0 410.9 659.4 665.6 582.7 0.0 0.0   Pre-tax profit without non-rec. items   182 312 527 848 854 750 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   57.7 48.3 39.0 61.2 118 98.7 0.0 0.0   Shareholders equity total   1,223 1,413 1,734 2,303 2,069 1,652 572 572   Interest-bearing liabilities   0.0 0.0 0.0 0.0 1,075 0.0 0.0 0.0   Balance sheet total (assets)   1,530 2,079 2,844 3,534 3,632 2,221 572 572   Net Debt   -332 -551 -290 -190 884 -688 -572 -572     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   982 1,193 1,344 1,559 1,353 1,379 0.0 0.0   Gross profit growth   -9.2% 21.5% 12.7% 16.0% -13.2% 1.9% -100.0% 0.0%   Employees   2 2 2 2 2 2 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,530 2,079 2,844 3,534 3,632 2,221 572 572   Balance sheet change%   8.7% 35.8% 36.8% 24.3% 2.8% -38.8% -74.3% 0.0%   Added value   182.0 300.3 515.7 818.4 832.4 717.1 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -11 -19 -19 9 38 -38 -99 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   16.8% 24.4% 37.7% 51.6% 60.5% 50.6% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   12.6% 17.5% 21.8% 27.0% 24.6% 28.2% 0.0% 0.0%   ROI %   16.1% 23.9% 33.7% 42.0% 32.0% 34.1% 0.0% 0.0%   ROE %   12.1% 18.4% 26.1% 32.7% 30.4% 31.3% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   79.9% 68.0% 61.0% 65.2% 57.0% 74.4% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -182.5% -183.4% -56.2% -23.2% 105.6% -96.0% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 52.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 5.3% 14.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   4.8 3.1 2.6 2.9 2.3 3.8 0.0 0.0   Current Ratio   4.8 3.1 2.6 2.9 2.3 3.8 0.0 0.0   Cash and cash equivalent   332.1 550.7 290.0 190.3 191.3 688.3 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   1,165.2 1,375.8 1,729.0 2,276.2 1,986.1 1,564.1 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   91 150 258 409 416 359 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   91 150 258 409 419 359 0 0   EBIT / employee   83 145 253 402 409 349 0 0   Net earnings / employee   70 121 205 330 333 291 0 0